BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26700620)

  • 1. An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese.
    Wang Y; Yu Y; Ye R; Zhang D; Li Q; An D; Fang L; Lin Y; Hou Y; Xu A; Fu Y; Lu W; Chen X; Chen M; Zhang M; Jiang H; Zhang C; Dong P; Li C; Chen J; Yang G; Liu C; Cai Z; Zhou F; Wu S
    Oncotarget; 2016 Jan; 7(3):2754-64. PubMed ID: 26700620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.
    Reinert T; Borre M; Christiansen A; Hermann GG; Ørntoft TF; Dyrskjøt L
    PLoS One; 2012; 7(10):e46297. PubMed ID: 23056278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved urine DNA methylation panel for early bladder cancer detection.
    Fang Q; Zhang X; Nie Q; Hu J; Zhou S; Wang C
    BMC Cancer; 2022 Mar; 22(1):237. PubMed ID: 35241014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
    Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Noninvasive Bladder Cancer Diagnosis using Urine Sediments and Novel DNA Methylation Biomarker Panels.
    Wang K; Tian Y; Xu H
    Clin Lab; 2016; 62(3):327-36. PubMed ID: 27156320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
    Chen PC; Tsai MH; Yip SK; Jou YC; Ng CF; Chen Y; Wang X; Huang W; Tung CL; Chen GC; Huang MM; Tong JH; Song EJ; Chang DC; Hsu CD; To KF; Shen CH; Chan MW
    BMC Med Genomics; 2011 May; 4():45. PubMed ID: 21599969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients.
    Yegin Z; Gunes S; Buyukalpelli R
    DNA Cell Biol; 2013 Jul; 32(7):386-92. PubMed ID: 23682613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cell-based DNA methylation classifier for monitoring bladder cancer.
    van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A
    Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
    Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
    Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profiling of urothelial carcinoma in bladder biopsy and urine.
    Pu RT; Laitala LE; Clark DP
    Acta Cytol; 2006; 50(5):499-506. PubMed ID: 17017434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers.
    Costa VL; Henrique R; Danielsen SA; Eknaes M; Patrício P; Morais A; Oliveira J; Lothe RA; Teixeira MR; Lind GE; Jerónimo C
    Epigenetics; 2011 Sep; 6(9):1120-30. PubMed ID: 21847011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
    Chung W; Bondaruk J; Jelinek J; Lotan Y; Liang S; Czerniak B; Issa JP
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1483-91. PubMed ID: 21586619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder.
    Ebbing J; Mathia S; Seibert FS; Pagonas N; Bauer F; Erber B; Günzel K; Kilic E; Kempkensteffen C; Miller K; Bachmann A; Rosenberger C; Zidek W; Westhoff TH
    World J Urol; 2014 Dec; 32(6):1485-92. PubMed ID: 24378824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer.
    Andersson E; Dahmcke CM; Steven K; Larsen LK; Guldberg P
    PLoS One; 2015; 10(7):e0131889. PubMed ID: 26151138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance and utility of a DNA methylation urine test for bladder cancer.
    Abern MR; Owusu R; Inman BA
    Urol Oncol; 2014 Jan; 32(1):51.e21-6. PubMed ID: 24360662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.